WallStreetZenWallStreetZen

NASDAQ: LXRX
Lexicon Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their LXRX stock forecasts and price targets.

Forecast return on equity

Is LXRX forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.5%

Forecast return on assets

Is LXRX forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

LXRX revenue forecast

What is LXRX's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$25.5M+2,015.45%
Avg 2 year Forecast
$71.6M+5,846.43%
Avg 3 year Forecast
$236.2M+19,520.43%
LXRX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

LXRX revenue growth forecast

How is LXRX forecast to perform vs Biotechnology companies and vs the US market?
Company
451.87%
Industry
37.57%
Market
10.16%
LXRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LXRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LXRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LXRX$1.61N/AN/A
CRBP$37.74$52.00+37.78%Strong Buy
REPL$6.42$37.67+486.71%Strong Buy
BMEA$10.98$55.80+408.20%Buy
ITOS$10.99$33.33+203.30%Strong Buy
View Top Biotech Stocks

Lexicon Pharmaceuticals Stock Forecast FAQ

What is LXRX's revenue growth forecast for 2024-2026?

(NASDAQ: LXRX) Lexicon Pharmaceuticals's forecast annual revenue growth rate of 451.87% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.57%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.16%.

Lexicon Pharmaceuticals's revenue in 2024 is $1,204,000.On average, 2 Wall Street analysts forecast LXRX's revenue for 2024 to be $6,271,650,099, with the lowest LXRX revenue forecast at $2,659,356,932, and the highest LXRX revenue forecast at $9,883,943,265. On average, 2 Wall Street analysts forecast LXRX's revenue for 2025 to be $17,629,320,331, with the lowest LXRX revenue forecast at $9,874,093,795, and the highest LXRX revenue forecast at $25,384,546,867.

In 2026, LXRX is forecast to generate $58,168,508,161 in revenue, with the lowest revenue forecast at $58,168,508,161 and the highest revenue forecast at $58,168,508,161.

If you're new to stock investing, here's how to buy Lexicon Pharmaceuticals stock.

What is LXRX's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: LXRX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is LXRX's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: LXRX) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.